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WHAT THIS PAPER ADDS?
 Some indications after previous endovascular aneurysm repair are known which may lead to open surgical conversions. These
conversions are technically demanding and associated with considerable mortality rates. Our study provides long-term results
following treatment of graft-related endoleaks by aortomonoiliac endografting after failed endovascular aneurysm repair. This
procedure represents a safe and feasible as well as less invasive alternative compared to open surgical conversion.a r t i c l e i n f o
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Objectives: To present long-term results of endoleak/endograft migration treatment by aortomonoiliac
(AMI) endografting after failed endovascular aneurysm repair (EVAR) of infrarenal abdominal aortic
aneurysms.
Design: Post hoc analysis of a prospectively gathered database at a tertiary care university hospital.
Materials and methods: From March 1995 to November 2010, 23 patients were identiﬁed who underwent
modiﬁcation into AMI conﬁguration after failed elective EVAR. Major causes for modiﬁcation were type I
(with/without endograft migration) or type III endoleaks with aneurysm expansion. An average increase
in aneurysm size of 1.6 cm (range: 1.5 to 10.5 cm) since initial aneurysm treatment was observed.
Interventional outcomes and long-term results were recorded for analysis.
Results: Technical success rate of AMI endografting was 95.65% (n ¼ 22). All except two endoleaks could
be successfully sealed with this manoeuvre (94.44%). Median time to modiﬁcation was 5.3 years
(interquartile range Q1eQ3: 1.3e9.3 years). No intra-operative conversion to open surgery was necessary
and mortality was 0%. Median follow-up was 44 months (interquartile range Q1eQ3: 17e69 months).
Conclusions: Treatment of graft-related endoleaks/endograft migration by AMI endografting after failed
EVAR represents a safe and feasible procedure. This approach broadens the minimal invasive opportu-
nities of aneurysm treatment, and open surgical conversion may be avoided except in selected patients.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Following the introduction of endovascular aneurysm repair
(EVAR), a minimal invasive alternative method to exclude abdom-
inal aortic aneurysms1 became available offering curative treat-
ment to high-risk otherwise incurable patients.2,3 Initially inspired
by open graft replacement, tube grafts were often deployed which
were later on replaced by bifurcated devices. The feasibility to
deploy grafts of bifurcated conﬁguration depends on arterialx: þ43 1 40400 5641.
auer).
ciety for Vascular Surgery. Publishanatomy. In case the iliac vessels are suitable to introduce, advance
and deploy grafts on one side only, devices of aortomonoiliac (AMI)
conﬁguration may be an alternative, although conjunction with
crossover bypass grafting is often required. This method has
already been reported in the early days of EVAR,4 and 5-year
patency rates of 83% have been presented.5 However, potential
complications like thrombosis and infection of the crossover bypass
graft or formation of pseudoaneurysms must be kept in mind.
Most adverse events after EVAR are successfully managed by
minimal invasive procedures using transarterial or translumbared by Elsevier Ltd. All rights reserved.
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aneurysm rupture, can be treated with a variety of options
including placement of proximal cuffs or Palmaz stents, distal
extension with or without coverage of hypogastric arteries, over-
stenting in case of component separation and coil embolisation of
the aneurysm sac itself.6,7 In addition, sealing of type II endoleaks
may also be achieved by catheter-based interventions. Neverthe-
less, some indications are knownwhich necessitate conversion into
open surgery. These include formation of endoleaks with aneurysm
enlargement refractory to secondary minimal invasive procedures
(e.g., type II endoleaks in which embolisation/clipping of the
persistent branch vessel failed), aneurysm sac expansion without
visualisation of an endoleak e a phenomenon entitled endo-
tension,8 graft thrombosis or infection and aortoenteric ﬁstula.
Moulakakis and co-workers9 performed a systematic literature
research regarding conversion to open repair and reported an
average mortality rate exceeding 10%. Therefore, the procedure is
considered a ‘hazardous procedure’.10
The purpose of this investigation was to present our experience
with AMI endografting as treatment option of graft-related endo-
leaks after failed EVAR and its long-term outcome. This approach
represents a less invasive procedure thereby avoiding major open
surgery in patients with otherwise untreatable endoleaks.
Patients and Methods
From March 1995 to November 2010, data of all consecutive
patients who received elective endovascular repair of their
infrarenal abdominal aortic aneurysm at our tertiary care university
hospital were collected prospectively and entered in an institu-
tional database. This date was chosen to ensure a minimum 1-year
follow-up. The database was reviewed to identify patients who
underwent endoleak treatment by AMI endografting after failed
EVAR. Our deﬁnition of; ‘failure’ was development of a graft-related
endoleak at the proximal/distal attachment site or a type III
endoleak following previous EVAR. Patients with type II endoleaks/
endotension were not treated with this approach. The decision
whether or not the modiﬁcation seems technically feasible was
always reached in an interdisciplinary consensus with interven-
tional radiologists. All subsequent secondary interventions were
documented and included in the analysis.
In the early years, EVAR was performed under ﬂuoroscopic
guidance in a specially equipped operating room with a ceiling-
mounted C-arm. Nowadays, deployment of endografts takes place
in an angiography suite. Endografts used in the investigation period
were commercially available. Prostheses were deployed by inter-
disciplinary teams of vascular surgeons and interventional radiol-
ogists. After removal of all angiography sheaths and wires the
procedure was completed by crossover bypass grafting to revas-
cularise the contralateral limb. Type, diameter, need of external
support as well as routing of the crossover bypass graft were left to
the surgeon’s preference.
Prior to discharge, a computed tomography (CT) scan was per-
formed to identify and classify possible endoleaks. According to our
protocol, postoperative follow-up included outpatient visits at 1, 3,
6 and 12 months combined with CT scans at 6 and 12 months as
well as annually thereafter. In general, colour-coded duplex ultra-
sonography scans were undertaken at the above-mentioned
appointments. In case that an increase in aneurysm diameter was
documented and an endoleak was presumed, CT angiography or
magnetic resonance angiography were performed. Endoleaks,
complications and post-procedural events were classiﬁed accord-
ing to deﬁnitions proposed by the Ad Hoc Committee for Stan-
dardized Reporting Practices in Vascular Surgery of The Society for
Vascular Surgery/American Association for Vascular Surgery.11During the more than 15-year observation period, 23 patients
underwent endoleak treatment by AMI endografting after failed
EVAR. All of these identiﬁed patients had presented either with
signiﬁcant accompanying risk factors at initial aneurysm exclusion
and have been classiﬁed to have an increased preoperative risk
proﬁle, as expressed by the American Society of Anesthesiologists
(ASA), class 3 or had a hostile abdomen. They have been consid-
ered at high risk for open surgery and therefore the less invasive
technique of EVAR was chosen. The mean aneurysm size at initial
exclusion was 6.5  1.4 cm (median: 6.0 cm, interquartile range
Q1eQ3: 5.5e7.4 cm). Mean age at modiﬁcationwas 76.8 6.3 years
(median: 77.6 years, interquartile range Q1eQ3: 74.4e81.6 years),
and 91.30% of them were men (n ¼ 21). All except one initially
placed endografts (95.65%) were of bifurcated conﬁguration and
one index endovascular repair was performed in an outlying
hospital (modiﬁcation rate: 3.5%). Noteworthy, the single tubular
endoprosthesis was implanted to treat a penetrating atheroscle-
rotic ulcer occurring in an inﬂammatory aneurysm. At time of
modiﬁcation, the mean aneurysm size was 8.1  2.9 cm (median:
7.8 cm, interquartile range Q1eQ3: 6.7e9.0 cm) with an average
increase in aneurysm size of 1.6 cm (median: 0.8 cm, interquartile
range Q1eQ3: 0.0e2.0 cm) since initial aneurysm exclusion. An
average time of 5.5 years (median: 5.3 years, interquartile range
Q1eQ3: 1.3e9.3 years) elapsed between the two procedures.
The predominant cause for modiﬁcationwas evidence of a graft-
related endoleak not treatable by local measures which resulted in
aneurysm expansion. Indications for modiﬁcation were 20 type Ia
or Ib endoleaks, 17 type III and one additional type IV endoleak.
Four patients underwent modiﬁcation during initial EVAR and
three of the procedures were labelled as technical failures in
Table 1. Sixteen patients had growing aneurysms and ﬁve had an
aneurysm of stable size (including the four patients with modiﬁ-
cation during initial EVAR). The remaining two patients initially
showed aneurysm size reduction but later on, complete disinte-
gration as well as fabric disruption of their Vanguard devices
occurred. Noteworthy, patient no. 15 did not follow the suggested
post-interventional surveillance CT scans and visits for more than 5
years and ultimately presented with a giant aneurysm of 17 cm. As
also seen in Table 1, the majority of patients underwent endoleak
correction procedures during follow-up. Type II endoleaks with
evidence of aneurysm enlargement were not treated with this
approach. Patients with these procedure-related endoleaks
underwent coil embolisation or clipping of the respective patent
collateral vessel, or CT-guided injection of thrombogenic
substances into the aneurysm sac.
Results
Successful deployment of the device was achieved in 95.65% of
patients. The single failure took place in patient no. 13 in whom the
right external iliac artery was considerably narrowed and the right
common iliac artery was elongated. Even after implantation of
a self-expandable stent and multiple balloon dilatations, the AMI
device could not be introduced as indicated in Table 2. The
combined type III and distal attachment leaks were successfully
treated by separate overstenting and distal extension. Femoro-
femoral bypass grafting completed the procedure because of pre-
existing thrombosis of the contralateral graft limb.
In 14 patients, the conﬁguration of AMI endografting consisted
of placement of the proximal end originating in the infrarenal aorta
and its distal landing zone in the right iliac axis. The iliac limb of the
device was carried to the right external iliac arteries in seven
patients. Occlusion of contralateral common iliac arteries was
achieved with application of Amplatzer Vascular Plugs 2, the Talent
Endoluminal Occluder System or embolisation using Cook IMWCE
Table 1
Summary of indications and previous correction procedures of patients undergoing aortomonoiliac modiﬁcation.
Patient Type of
device
Endoleak during
follow-up
Endoleak treatment during
follow-up
AAA sac at
modiﬁcation
(cm)
AAA sac change
since EVAR (cm)
Indication for
modiﬁcation
Time to
modiﬁcation
(months)
1 Stentor Type IIIa Overstenting 4.8 0.8 Proximal type I 119
Type II No therapy Distal type I
Type IIIb
2 Stentor Distal type I Right iliac limb extension 6.7 0.7 Type IIIa 109
Type IV
3 Stentor Type IIIa Overstenting 7.5 2.0 Proximal type Ia 94
Distal type I Right iliac limb extension Type IIIa
4 Vanguard Type IIIa Overstenting 12.3 4.7 Proximal type Ia 81
Proximal type Ia Proximal cuff placement Type IIIa
Type II Embolisation of IMA
Type IIIa Overstenting
5 Vanguard Type II Coil embolisation, laparoscopic
clipping of IMA
6.7 1.2 Type IIIb 150
6 Vanguard Proximal type I Proximal extension (Passager) 6.9 1.9 Type IIIb 116
Type IIIa Overstenting
7 Vanguard No endoleak e 7.8 0.8 Proximal type Ia 44
Distal type I
Type IIIa
8 Vanguard Distal type I Left iliac limb extension 6.8 1.0 Proximal type Ia 87
Type IIIb
9 Excluder Proximal type Ia Proximal cuff placement 8.5 2.5 Distal type I 59
Type IIIa
10 Vanguard Distal type I Left iliac limb extension 3.2 1.5 Type IIIb 148
11 Excluder Type II Coil embolisation of lumbar artery 11.8 5.7 Distal type I 141
Type IIIa
12 Vanguard Type IIIa Overstenting 6.1 1.6 Type IIIb 69
13 Vanguard Distal type I Left iliac limb extension 8.6 0.6 Distal type I 48
Type II Coil embolisation of lumbar artery Type IIIb
Type IIIa Overstenting
14 Vanguard Type II Coil embolisation of lumbar artery 9.2 3.7 Proximal type I 64
Type II Coil embolisation of IMA, CT-guided
thrombin injection
Distal type I
Type IIIa
15 Excluder Type II No therapy 17.0 10.5 Distal type I 114
Type IIIa
16 Zenith No endoleak e 6.0 0.0 Technical failure 0
17 Zenith Type II No therapy 7.2 0.0 Distal type I with
cranial migration
50
18 Talent No endoleak e 7.8 0.0 Proximal type Ia 0
19 Talent No endoleak e 7.8 0.0 Technical failure 0
Proximal type Ia
20 Talent Proximal type I Proximal extension (Palmaz) 8.8 1.8 Proximal type Ia 28
Type II Embolisation of IMA, operative
ligation
Type IIIa
Type IIIa Overstenting
21 Talent No endoleak e 10.0 0.1 Proximal type Ia 0.3
Type IIIa
22 TAG thoracic Type II No therapy 4.8 0.3 Distal type I with
cranial migration
2
23 Excluder No endoleak e 9.1 0.0 Technical failure 0
Proximal type Ia
AAA: abdominal aortic aneurysm; EVAR: endovascular aneurysm repair; IMA: inferior mesenteric artery.
a With distal migration of endograft.
Table 2
Characteristics of aortomonoiliac modiﬁcation.
No. of patients
(n ¼ 23)
Distal landing zone of
aorto-monoiliac grafta
Right CIA 7
Right EIA 7
Left CIA 6
Left EIA 2
Fate of contralateral graft limb
Endovascular occlusion 19
Preexisting limb thrombosis 4
Crossover bypass graft
Femoro-femoral 17
Ilio-femoral 6
CIA: common iliac artery; EIA: external iliac artery.
a Not successful deployment of endograft (n ¼ 1).
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contralateral occlusion due to already thrombosed graft limbs. Two
patients had previous crossover bypass grafting and two patients
suffered from newly occurring symptoms of disabling claudication.
Therefore, crossover bypass grafting was performed to revascular-
ise the respective limb. Type and diameter of the crossover graft
varied according to the surgeon’s preference and patients charac-
teristics and was between 7 mm and 12 mm. The crossover graft
was tunnelled anterior to the rectus sheath in 15 patients while in
the remaining ones the graft was routed through the space of
Retzius. A conﬁguration overview after modiﬁcation is given in
Table 2. Talent AMI devices were used in 17 patients whereas the
remaining received Endurant (n ¼ 2), Zenith (n ¼ 2) and
Valiant (n ¼ 1) endografts with diameters ranging from 24 mm to
34 mm.
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with this manoeuvre (34 of 36 endoleaks, 94.44%). Merely, in
patient no. 20 with multiple previous correction procedures, the
endoleaks still remained and caused further aneurysm expansion.
He ultimately had to undergo endograft explantation and aorto-
femoral bypass grafting. During modiﬁcation procedures into AMI
conﬁguration, no conversion to open surgery was necessary. There
were no perioperative or in-hospital deaths in patients who
received AMI endografting after failed EVAR.
Early modiﬁcations
A total of ﬁve modiﬁcation procedures were performed within
30 days. Technical failures included inability to introduce the
contralateral iliac limb in retrograde as well as via crossover tech-
nique. In one patient each, insufﬁcient opening of the endograft
itself and, alternatively, the ipsilateral iliac limbwere observed. The
fourth patient with intraprocedural modiﬁcation presented at
completion angiography with a proximal type I endoleak due to
distal migration of the endograft which could not be sufﬁciently
treated by cuff placement. In addition, another patient with a type
Ia endoleak complicated by distal migration of the endograft
combined with modular disconnection was transferred to our
institution 1 week after index EVAR in an outlying hospital. In all of
these patients, modiﬁcation procedures were successful and both
occurring endoleaks were already detectedwithin the hospital stay.
The type II endoleak arising from a lumbar artery was observed
while one redo endovascular procedure took place to seal the
incomplete occluded contralateral iliac artery (Table 3).
Delayed modiﬁcations
The remaining eighteen modiﬁcations were undertaken later
than 1 month after initial EVAR and therefore classiﬁed as delayed
procedures (78.26%). Table 3 summarises complications, endoleaks
and adverse events after AMI modiﬁcation. The second type II
endoleak observed has not been described until after the modiﬁ-
cation procedurewhich was done because of a combined type III/IVTable 3
Complications, endoleaks, and adverse events after aortomonoiliac modiﬁcation.
Treatment Number
Early (within 30 days)
Iliac artery dissection PTA and stent placement 1
Type Ic Redo endovascular occlusion 2
Type II endoleak (via patent
lumbar artery)
No therapy 1
Type IV endoleak No therapy 1
Groin Haematoma Surgical evacuation 2
Lymphatic ﬁstula Conservative 2
Buttock claudication Conservative 1
Delayed (>30 days)
Endograft and crossover
bypass thrombosis
Axillo-bi-femoral bypass
grafting
1
Peripheral thrombo-embolic
event
Embolectomy 1
Crossover bypass infection Axillo-femoral bypass
grafting
1
Type Iaa Proximal extension 1
Type Iba Distal extension 2
Type II endoleak (via patent
lumbar artery)
No therapy 1
Type III endoleak No therapy 1
Endograft stenosis PTA 2
PTA and stent placement 2
Mortality rate (0%) 0
PTA: percutaneous transluminal angioplasty.
a Occurring in one patient.endoleak. It is most likely that the endoleak via the lumbar artery
already existed before the modiﬁcation and could not be differen-
tiated from the other endoleaks. As the aneurysm diameter
remained stable during follow-up, no further intervention was
performed. A small type III endoleak occurred in an 84-year-old
multimorbid patient and was therefore carefully monitored by
surveillance CT scans as it did not result in aneurysm expansion.
Noteworthy, the depicted type Ia and Ib endoleaks all occurred in
one patient. He developed a proximal as well as distal attachment
endoleak resulting in aneurysm expansion. Three years after
modiﬁcation, the 77-year-old patient had to undergo debranching
of the visceral aorta and subsequent revascularisation of the
superior mesenteric and the left renal artery to elongate the
proximal aortic neck region and facilitate endovascular treatment
of the type Ia endoleak. Both endoleaks could be successfully
treated by endovascular relining using a second Talent AMI graft.
Another 3 years after successful cessation of these leaks, a new
distal attachment leak was observed which was treated by embo-
lisation of the ipsilateral hypogastric artery and extension of the
graft into the external iliac artery. Buttock claudicationwas present
in one patient in whom the right hypogastric artery was occluded
prior to the modiﬁcation procedure. Reduction in endograft ﬂow
because of device stenosis necessitating catheter-based interven-
tions occurred in three patients.
Three major complications occurred in one patient. First, he
received percutaneous transluminal angioplasty including stent
placement within the initial hospital stay because of iliac artery
dissection and stenosis. Twelve months after the modiﬁcation
procedure he presented with thrombosis of the AMI as well as the
crossover bypass graft and subsequently received axillo-bi-femoral
bypass grafting. On the same day he had to undergo embolectomy
due to a peripheral thrombo-embolic event. In the other patient,
infection of the crossover bypass graft 2 months after the modiﬁ-
cation procedure was diagnosed. The infected crossover graft was
explanted and the procedure was completed by axillo-femoral
bypass. Noteworthy, the patient, in whom the modiﬁcation proce-
dure was not successful, developed ischaemic colitis with bowel
necrosis which necessitated left-sided colectomy. She was dis-
charged 3 weeks later and survived for almost 3 years. All patients
survived the management procedures due to complications
depicted in Table 3.
Follow-up
During a mean follow-up of 43 months (median: 44 months,
interquartile range Q1eQ3: 17e69 months), the mean aneurysm
diameter decreased to 7.7  3.5 cm (median: 7.0 cm, interquartile
range Q1eQ3: 4.8e10.0 cm). This represents an average decrease of
0.4 cm (median: 0.0 cm, interquartile range Q1eQ3: 0.5 to
0.0 cm). Overall survival of this patient group at 1, 4 and 7 years was
90%, 73% and 37%, respectively. One patient did not follow the
suggested post-interventional surveillance CT scans and visits for
more than 3 years and sustained fatal late aneurysm rupture 51
months after the modiﬁcation procedure.
Discussion
Almost 20 years have elapsed since the pioneers of EVAR re-
ported their experience. Subsequently, the frequency of the
procedure grew substantially12 and it became an accepted alter-
native to conventional open graft replacement of abdominal aortic
aneurysms. Due to the minimal invasive technique, a method of
aneurysm exclusion in otherwise incurable patients because of
their extensive accompanying risk factors was at hand.2,13 Never-
theless, the beneﬁts of this approach do not come freely. Endoleaks
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lead to aneurysm sac enlargement which even may occur several
years after initial endograft treatment.
Secondary interventions to maintain aneurysm exclusion are
frequent and endoleak treatment by catheter-based interventions
is nearly always possible but even open surgical conversion may
sometimes be required. This procedure may be necessary in
a variety of indications following primary EVAR. The frequency of
conversion to open repair is reported widely in the literature and is
depending on centre experience, indications seen for conversion,
generation of implanted grafts and length of follow-up.14 Large
single-centre reviews publish incidences of this procedure to be
around 2%.15e17 The rate of conversionwas somewhat higher (8.6%)
analysing long-term results of EVAR with the ﬁrst generation of
commercially available stent grafts.18
Frequency of open surgical conversion is rather lowcompared to
the high numbers of secondary catheter-based interventions.
Nevertheless, it represents an increased burden to the patient due
to the even more extensive dissection compared to conventional
primary open graft replacement. Sometimes, open conversions
have to be performed immediately during initial EVAR due to
technical difﬁculties such as endograft misdeployment or intra-
operative vessel injury. These acute emergent as well as peri-
interventional conversions within 30 days following primary
endograft placement are accompanied with unfavourable mortality
rates which exceed 20%.14,19 Secondary conversions deﬁned as any
open graft replacement performed later can be felt necessary either
under elective conditions or in an emergent manner because of
aneurysm rupture. In most cases, patients present with higher
operative risk due to meanwhile advanced age and probably
worsened co-morbidities present at time of conversion as
compared to primary aneurysm exclusion. Furthermore, presence
of the endograft increases the technical challenge during open
surgical conversion. Because only a small amount of patients having
undergone secondary conversion under elective conditions are
published, it is difﬁcult to precisely estimate mortality rates. The
results vary from no deaths20 up to 25% as reported in an analysis of
a French multicentric study.19
The use of AMI grafts along with crossover bypass grafting has
broadened the applicability of endovascular techniques in
abdominal aortic aneurysm exclusion. Patients with complex
arterial anatomy who might not be candidates for bifurcated
endografting can be treated with this approach. Although concerns
were raised that the additional extra-anatomic reconstruction in
the groin may increase the incidence of possible complications, and
limits thereby the durability of the procedure, encouraging mid-
and long-term patency rates were published.5 Cumulative patency
rate was 91% at 3 years and 83% at 5 years. Lipsitz et al.21 reported
that patency rates of crossover grafts in conjunction with EVAR
surpass those performed for occlusive disease. Therefore, Yilmaz
and co-workers22 concluded in their analysis of 148 patients that
the need for additional extra-anatomic bypass grafting should not
discourage the use of AMI devices in patients with anatomy
unfavourable for other EVAR approaches. Although a multicentre
randomised study showed that late patency was higher after direct
bypass than crossover bypass in good-risk patients with unilateral
iliac occlusive disease not amenable to angioplasty,23 the use of AMI
endografting combined with crossover bypass grafting compared
to bifurcated endografting did not independently increase the risk
of major complication during follow-up.24 Similarly, Lazaridis and
co-workers25 concluded that AMI conﬁguration for elective aneu-
rysm repair has proven to be safe and efﬁcacious. In addition, they
reported that long-term follow-up results compare well with
primarily reported results for endografting using bifurcated
endoprostheses.Modiﬁcation into AMI conﬁgurationwas previously described to
seal a type III endoleak26 or alternatively to treat aneurysm
expansion in the absence of an endoleak.27 Recently, Baril and co-
workers28 summarised, after 15 of these modiﬁcations, that AMI
devices offer a more durable repair than proximal cuff placement
for treatment of proximal type I endoleaks as they presented
successful repairs in 86% of patients compared to 45% treated with
proximal cuffs. Our ﬁndings regarding treatment of these proximal
attachment endoleaks are consistent as we could seal more than
90% with this procedure. The achieved overall success rate of 95% is
in accordance to the results from the analysis of the Zenith Renu
AAA Ancillary Graft Converter.29 Follow-up length of our patient
cohort is exceeding theirs29 which enables us to draw relatively
safe conclusions.
Conclusion
Frequency of open surgical conversion after primary EVAR is
rather low but the procedure is technically demanding and repre-
sents a remarkable operative burden to the patient being more
extensive compared to standard primary open graft replacement.
Therefore, the procedure should be performed only as a last
opportunity under strict indication. Considering the large numbers
of endografts being implanted worldwide, the issue of modiﬁcation
into AMI conﬁguration will increase in importance. This procedure
allows safe and effective treatment of graft-related endoleaks
representing a harbinger of aneurysm rupture. Especially when
multiple graft-related endoleaks are present, AMI endografting
successfully relines the entire length of the previously implanted
device. With this procedure, a minimally invasive alternative is at
hand and open surgical conversion may be avoided in many
instances.
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